MOUNTAIN VIEW, CA — (Marketwired) — 02/17/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the first clinical procedure in the United States with the Magellan Robotic Catheter eKit (MRC eKit). Interventional Radiologist, Dr. Ripal Gandhi, performed the procedure at Miami Cardiac & Vascular Institute (MCVI) in Miami, FL. Dr. Gandhi used the MRC eKit during a robotic transarterial chemoembolization (TACE) procedur
MOUNTAIN VIEW, CA — (Marketwired) — 02/02/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the Magellan Robotic Catheter eKit (MRC eKit). The MRC eKit is the company–s latest addition to the family of approved Magellan Robotic Catheters and helps extend robotic capabilities and control throughout procedures in the peripheral vasculature. With the MRC eKit, physici
BEAVERTON, OR — (Marketwired) — 02/01/16 — Cascade Microtech, Inc. (NASDAQ: CSCD) will release financial results for its fourth quarter and year ended December 31, 2015 at approximately 4:00 p.m. EST (1:00 p.m. PST), on Monday February 8, 2016. The company will host a conference call beginning at 5:00 p.m. EST (2:00 p.m. PST) that same afternoon to discuss these results.A simultaneous audio cast of the conference call may be accessed online from the investor relations page at , or call: 855-
MOUNTAIN VIEW, CA — (Marketwired) — 01/14/16 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provided an update of key corporate initiatives which, if successful, will expand the utility and regulatory labeling of the Sensei® and Magellan product lines:This study is a prospective, single arm study of the Hansen Sensei System for introducing and positioning RF ablation catheters in subjects with paroxysmal atrial fibrillation (PAF). As of January
MOUNTAIN VIEW, CA — (Marketwired) — 01/14/16 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, announced today that its board of directors has entered a process to explore strategic alternatives for the company focused on enhancing stockholder value, including, but not limited to, a licensing transaction, a refinancing transaction, a strategic business combination, partnership, a possible sale or disposition of one or more corporate assets or the company its